Honeywell
HON
$208.11
-2.24%
Honeywell International is a global multi-industry industrial technology company operating through four primary segments: Aerospace Technologies, Building Automation, Process Automation and Technology, and Industrial Automation, with a substantial installed base that generates roughly one-third of revenue from recurring aftermarket services. The company is a legacy industrial conglomerate with a 100,000-person workforce and a portfolio spanning avionics, building controls, process solutions, and warehouse automation, positioning it as a diversified supplier to aerospace, commercial construction, energy, and manufacturing end markets. The current investor narrative is dominated by a major structural transformation: Honeywell has completed the spin-off of its Aerospace Technologies unit and is separating into three independent companies, leaving Honeywell Technologies as a pure-play automation and sustainability business. Recent headlines highlight strong automation demand and AI tailwinds for the remaining entity, but the spin-off has also introduced near-term earnings volatility and investor uncertainty, with the newly standalone aerospace business reporting a sharp pro forma earnings decline and weak guidance. The debate centers on whether the leaner Honeywell can accelerate growth and command a higher multiple as a focused automation play, or whether portfolio disruption and soft industrial demand will weigh on results.…
HON
Honeywell
$208.11
Related headlines
Investment Opinion: Should I buy HON Today?
HON is rated a Hold. The core thesis is that the company's transformation into a pure-play automation leader offers long-term value, but near-term earnings uncertainty and revenue declines warrant caution. The analyst consensus is 'buy' with an average target of $258.22, implying 20.7% upside, but the wide target range ($186-$303) reflects high uncertainty. The stock's 4.55% dividend yield provides income support, but the forward PE of 21.71x is not cheap relative to the company's current growth trajectory.
Supporting evidence for a Hold includes: (1) the forward PE of 21.71x is in line with the industrial sector average of 20-25x, but the trailing PE of 13.82x is distorted by one-time gains; (2) revenue declined 6.11% year-over-year in Q2 2026, and the company has not demonstrated an ability to grow organically; (3) operating margin of 17.5% is respectable but gross margin has compressed to 37.6% from 38.9%; (4) free cash flow yield of 6.3% is modest and limits upside; and (5) the dividend yield of 4.55% is attractive but the payout ratio of 62.9% leaves little buffer. The stock trades at a discount to its historical PS ratio of 7x, but this is largely due to the reduced revenue base post-spin-off.
The biggest risks that could invalidate the thesis are: (1) a continued decline in revenue and margins, leading to earnings misses; (2) failure to realize cost synergies or growth from the automation focus; and (3) a broader industrial slowdown that compresses multiples. The rating would upgrade to Buy if revenue growth turns positive and the forward PE compresses below 18x, or downgrade to Sell if revenue declines accelerate beyond -10% and operating margins fall below 15%. Relative to its history and peers, HON appears fairly valued, with the market pricing in a successful transformation that has yet to be proven.
Sign up to view all
HON 12-Month Price Forecast
Honeywell is in a transitional period following the aerospace spin-off, with near-term fundamentals weak but long-term potential intact. The stock is fairly valued on a forward basis, and the high dividend yield offers downside protection. However, the lack of revenue growth and margin compression are concerns that need to be resolved. The AI assessment is neutral with medium confidence, as the bull and bear cases are balanced. An upgrade to bullish would require evidence of revenue growth acceleration and margin expansion, while a downgrade to bearish would follow continued revenue declines and earnings misses. The key monitorable is the next earnings report, particularly revenue growth and operating margin trends.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Honeywell's 12-month outlook, with a consensus price target around $258.26 and implied upside of +24.1% versus the current price.
Average Target
$258.26
0 analysts
Implied Upside
+24.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$186 - $303
Analyst target range
Honeywell is covered by 23 analysts, with a consensus recommendation of "buy" and a recommendation mean of 2.0 on a scale where 1 is a strong buy and 5 is a strong sell. The average target price is $258.22, which implies 20.7% upside from the current price of $213.99. The consensus leans bullish, with the majority of analysts maintaining positive ratings, as evidenced by recent actions from RBC Capital (Outperform), JP Morgan (Overweight), BMO Capital (Outperform), Mizuho (Outperform), and Citigroup (Buy). However, there is some caution, with Morgan Stanley maintaining an Equal Weight rating and B of A Securities upgrading from Underperform to Neutral, indicating a mixed but generally constructive sentiment.
The target price range is wide, from a low of $186.00 to a high of $303.00, representing a 63% spread between the two. The high target of $303.00 would imply a 41.6% upside and likely assumes successful execution of the spin-off strategy, accelerating automation demand, and multiple expansion as the market rewards the leaner company. The low target of $186.00 implies a 13.1% downside and likely prices in margin compression, competitive pressures, or a broader industrial slowdown. The wide spread signals high uncertainty among analysts, which is typical for a company undergoing a major structural transformation. The estimated EPS average of $12.76 for the forward year suggests that analysts expect earnings to normalize after the spin-off, and the estimated revenue average of $24.02 billion reflects expectations for the remaining businesses. Overall, the analyst community sees meaningful upside but acknowledges significant execution risk.
Drowning in data?
Find the real signal!
Bulls vs Bears: HON Investment Factors
The bear case currently has stronger evidence due to deteriorating fundamentals: revenue is declining at -6.11% year-over-year, forward earnings are expected to fall (forward PE of 21.71x vs. trailing 13.82x), and the stock has significantly underperformed the market over the past six months. However, the bull case rests on the successful execution of the spin-off strategy, which could unlock value as a pure-play automation company with AI tailwinds, as evidenced by the consensus 'buy' rating and 20.7% average upside to analyst targets. The single most important tension is whether the leaner Honeywell can return to revenue growth and expand margins, or whether the portfolio disruption and soft industrial demand will continue to weigh on results. If revenue growth turns positive and margins stabilize, the stock could re-rate toward the analyst average target; if not, it risks testing the 52-week low.
Bullish
- Analyst consensus sees 20.7% upside: 23 analysts rate HON a 'buy' with an average target price of $258.22, implying 20.7% upside from the current $213.99. The high target of $303.00 suggests 41.6% upside if the automation-focused strategy executes successfully.
- Attractive dividend yield with sustainable payout: HON offers a 4.55% dividend yield, well above the industrial sector average, supported by a 62.9% payout ratio. The company paid $795 million in dividends in Q2 2026, demonstrating commitment to shareholder returns even during the spin-off transition.
- Reasonable forward valuation vs. history: The forward PE of 21.71x is in line with the industrial sector average of 20-25x, while the trailing PE of 13.82x is near the low end of its historical 10-18x range. The EV/EBITDA of 10.66x and PS ratio of 1.75x appear reasonable for a diversified industrial with recurring aftermarket revenue.
- Strong ROE and profitability metrics: HON's ROE of 30.6% and operating margin of 17.5% are robust for an industrial conglomerate. Q2 2026 operating income was $1.737 billion, and the company remains solidly profitable on an operating basis despite spin-off-related noise.
Bearish
- Revenue declining year-over-year: Q2 2026 revenue of $9.719 billion represents a -6.11% decline from the prior-year quarter, following a -6.9% drop in Q1 2026. The remaining businesses are not growing fast enough to offset portfolio changes and macro headwinds.
- Forward PE exceeds trailing PE, signaling earnings decline: The forward PE of 21.71x is significantly higher than the trailing PE of 13.82x, an unusual inversion that implies trailing earnings are inflated by one-time gains (such as the $5.792 billion other income in Q2 2026) and that normalized earnings will be lower.
- Elevated leverage and weak cash flow conversion: Debt-to-equity stands at 2.24, and TTM free cash flow of $4.119 billion represents only a 6.3% yield on the $65.4 billion market cap. The current ratio of 1.32 is adequate but not strong, and Q2 2026 saw a net cash decrease of $3.226 billion due to debt repayment and acquisitions.
- Margin compression and earnings volatility: Gross margin declined to 37.6% in Q2 2026 from 38.9% a year earlier, and the company reported a net loss of $115 million in Q4 2025. The spin-off has introduced significant earnings volatility, with Q2 2026 net income inflated by a one-time gain.
HON Technical Analysis
Honeywell is in a range-bound consolidation with a modest longer-term uptrend that has recently lost momentum. The stock's 1-year price change is +7.60%, but it sits at $213.99, which is only 26.3% of its 52-week range of $195.87 to $260.28, meaning it is trading much closer to the bottom than the top of its annual band. This positioning suggests the market has de-rated the shares from their highs, and while the stock is not at a fresh low, it lacks the momentum characteristic of a sustained uptrend. The 52-week high of $260.28 represents 21.6% upside from current levels, while the 52-week low of $195.87 is 8.5% below, framing a wide but downward-skewed trading envelope.
Short-term momentum has improved even as medium-term performance remains weak, creating a notable divergence. The 1-month change is +3.84%, outpacing the S&P 500's +0.59% by 3.25 percentage points, but the 3-month change is -6.90% and the 6-month change is -6.74%, both significantly worse than the index's +3.34% and +17.35% respectively. This pattern of a positive 1-month bounce within a negative 3- and 6-month trend suggests a mean-reversion rally or temporary pullback rather than a confirmed trend reversal, especially given the stock's relative strength versus SPY is -10.24% over 3 months and -24.09% over 6 months. The YTD change of +9.25% is positive but trails SPY's +12.86%, indicating the stock has been a relative laggard for most of the year despite the recent bounce.
Key technical levels are defined by the 52-week low at $195.87 as support and the 52-week high at $260.28 as resistance. A breakdown below $195.87 would signal a deeper bearish trend and likely invite further selling, while a breakout above $260.28 would confirm a new uptrend and could attract momentum buyers. The stock's beta of 0.901 indicates it is about 10% less volatile than the broader market, which is typical for a large-cap industrial and implies that position sizing can be slightly larger for the same risk budget, though the max drawdown of -19.06% shows the stock is not immune to sharp declines. The short ratio of 2.71 suggests short interest is moderate and not a major near-term catalyst.
Beta
0.89
0.89x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$196-$260
Price range past year
Annual Return
+5.7%
Cumulative gain past year
| Period | HON Return | S&P 500 |
|---|---|---|
| 1m | -0.7% | +0.9% |
| 3m | -6.9% | +3.4% |
| 6m | -11.5% | +14.4% |
| 1y | +5.7% | +16.2% |
| ytd | +6.2% | +14.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HON Fundamental Analysis
Honeywell's revenue trajectory has turned negative on a year-over-year basis, with Q2 2026 revenue of $9.719 billion representing a -6.11% decline from the prior-year quarter. This follows a pattern of sequential softness: Q1 2026 revenue was $9.143 billion, down from $9.822 billion in Q1 2025, and Q4 2025 revenue of $6.860 billion was well below the $10.088 billion reported in Q4 2024, though the Q4 2025 figure likely reflects the aerospace spin-off and reclassification. The segment breakdown for the most recent period shows Aerospace Technologies at $4.532 billion, Building Automation at $2.002 billion, Process Automation and Technology at $1.679 billion, and Industrial Automation at $1.501 billion, with Aerospace still the largest contributor despite the spin-off. The revenue decline is a concern for the investment case, as it suggests the remaining businesses are not growing fast enough to offset portfolio changes and macro headwinds.
Profitability remains solid but has been volatile due to one-time items and the spin-off. Q2 2026 net income was $5.682 billion, but this was inflated by a $5.792 billion gain in total other income, resulting in an unusually high net margin of 58.5%; excluding that, operating income was $1.737 billion with an operating margin of 17.9%. Gross margin in Q2 2026 was 37.6%, down from 38.9% in Q2 2025, indicating some compression. The trailing twelve-month net margin is 12.6% and the operating margin is 17.5%, which are respectable for an industrial conglomerate but reflect the impact of the Q4 2025 net loss of $115 million and the Q1 2026 net income of $821 million. The company remains profitable on an operating basis, but the margin trend bears watching.
Honeywell's balance sheet shows elevated leverage, with a debt-to-equity ratio of 2.24 and a current ratio of 1.32. Free cash flow for Q2 2026 was $961 million, but TTM free cash flow is $4.119 billion, which is relatively modest against a market cap of $65.4 billion, implying a free cash flow yield of about 6.3%. The company returned cash to shareholders with $795 million in dividends paid in Q2 2026, and the dividend yield is 4.55%, supported by a payout ratio of 62.9%. ROE is strong at 30.6%, but this is partly a function of leverage. The cash flow statement shows a net change in cash of -$3.226 billion in Q2 2026, driven by $2.735 billion in debt repayment and $646 million in acquisitions, indicating the company is actively managing its capital structure post-spin-off.
Quarterly Revenue
$9.7B
2026-06
Revenue YoY Growth
-6.1%
YoY Comparison
Gross Margin
37.6%
Latest Quarter
Free Cash Flow
$4.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HON Overvalued?
Because Honeywell is profitable with positive net income, the PE ratio is the primary valuation metric. The trailing PE is 13.82x, while the forward PE is 21.71x, which is unusual because the forward multiple is higher than the trailing. This inversion implies that the trailing earnings are inflated by one-time gains (such as the $5.792 billion other income in Q2 2026) and that the market expects normalized earnings to be lower, or that the spin-off has reduced the earnings base. The forward PE of 21.71x is more representative of the ongoing business and suggests the market is pricing in a recovery in earnings power.
Compared to the broader industrials sector, Honeywell's forward PE of 21.71x is roughly in line with or slightly below the sector average, which typically ranges from 20x to 25x. The price-to-sales ratio is 1.75x, and the EV/EBITDA is 10.66x, both of which appear reasonable for a diversified industrial with mid-single-digit growth prospects. The price-to-book ratio is 4.23x, which is on the higher side but reflects the company's strong ROE of 30.6%. The dividend yield of 4.55% is attractive and well above the sector average, providing support for the valuation. Overall, the stock does not appear expensive on a forward basis, but the premium to its own historical trailing PE is notable.
Historically, Honeywell's PE ratio has ranged from around 10x to 18x over the past few years, with the current trailing PE of 13.82x near the lower end of that range. However, the forward PE of 21.71x is above the historical average, suggesting the market is anticipating a rebound in earnings that may not yet be reflected in the trailing figures. The PS ratio of 1.75x is also below the historical average of around 7x, but this is largely due to the reduced revenue base after the spin-off. The current valuation appears to offer a reasonable entry point for long-term investors, but the elevated forward multiple relative to history warrants caution.
PE
13.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 9x~17x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.7x
Enterprise Value Multiple
Investment Risk Disclosure
Honeywell faces significant financial and operational risks stemming from its recent structural transformation. The company's debt-to-equity ratio of 2.24 is elevated, and TTM free cash flow of $4.119 billion provides only a 6.3% yield on market cap, limiting financial flexibility. Revenue declined 6.11% year-over-year in Q2 2026, and gross margin compressed to 37.6% from 38.9% a year earlier, indicating pricing pressure and mix headwinds. The spin-off of Aerospace Technologies has introduced earnings volatility, with Q4 2025 showing a net loss of $115 million and Q2 2026 net income inflated by a $5.792 billion one-time gain, making underlying profitability difficult to assess. Additionally, the company's payout ratio of 62.9% leaves little room for error if earnings decline further.
Market and competitive risks are substantial given the company's premium forward valuation and cyclical end-market exposure. The forward PE of 21.71x is above the trailing PE of 13.82x, implying the market expects a significant earnings rebound that may not materialize if industrial demand remains soft. With a beta of 0.901, HON is less volatile than the market, but it remains sensitive to macroeconomic cycles, particularly in commercial construction, energy, and manufacturing. Competitive pressures in automation and building controls are intensifying, and the company's ability to capitalize on AI tailwinds is unproven. Recent news highlights that the newly standalone aerospace business reported a 32% pro forma earnings decline and weak guidance, which could spill over and dampen sentiment for the remaining Honeywell.
The worst-case scenario involves a continued decline in revenue, margin compression, and a failure to achieve expected synergies from the spin-off, leading to earnings misses and analyst downgrades. In this scenario, the stock could retest its 52-week low of $195.87, representing an 8.5% downside from the current price of $213.99. If broader industrial demand weakens further, the stock could fall to the analyst low target of $186.00, implying a 13.1% decline. A more severe downturn, driven by a recession and multiple compression, could push the stock below $180, a 16% drop. The max drawdown of -19.06% over the past year illustrates the potential for sharp declines.
FAQ
The key risks include: (1) Financial risk: high debt-to-equity of 2.24 and modest free cash flow yield of 6.3% limit flexibility; (2) Operational risk: revenue declined 6.11% year-over-year and gross margin compressed to 37.6%, with earnings volatility from the spin-off; (3) Market risk: the stock has underperformed the S&P 500 by 24.09 percentage points over six months and could test its 52-week low of $195.87; (4) Competitive risk: intensifying competition in automation and building controls could pressure pricing and market share. The most severe risk is a continued revenue decline leading to earnings misses and a drop to the analyst low target of $186.
The 12-month forecast has three scenarios: Bull case (25% probability) targets $260-$303, assuming successful spin-off execution and revenue acceleration; Base case (55% probability) targets $240-$260, assuming gradual stabilization and meeting EPS estimates of $12.76; Bear case (20% probability) targets $186-$200, assuming continued revenue declines and margin compression. The base case is most likely, with the key assumption that revenue growth turns slightly positive by Q4 2026 and operating margins hold around 17.5%. The analyst average target of $258.22 aligns with the base case.
HON appears fairly valued on a forward basis. The forward PE of 21.71x is in line with the industrial sector average of 20-25x, while the trailing PE of 13.82x is near the low end of its historical range of 10-18x. The PS ratio of 1.75x is below the historical average of 7x, but this reflects the reduced revenue base post-spin-off. The EV/EBITDA of 10.66x is reasonable for a diversified industrial. The dividend yield of 4.55% is attractive and provides support. The market appears to be pricing in a successful transformation, with earnings expected to normalize at $12.76 per share. If the company fails to deliver, the stock could be overvalued at current levels.
HON may be a good buy for income-focused investors willing to accept near-term uncertainty. The stock offers a 4.55% dividend yield and trades at a forward PE of 21.71x, which is in line with the industrial sector. Analyst consensus is 'buy' with an average target of $258.22, implying 20.7% upside. However, revenue declined 6.11% year-over-year in Q2 2026, and the forward PE exceeds the trailing PE, indicating expected earnings decline. The biggest downside risk is a retest of the 52-week low of $195.87, representing 8.5% downside. For risk-averse investors, waiting for evidence of revenue growth stabilization may be prudent.
HON is more suitable for long-term investment, given its 4.55% dividend yield, low beta of 0.901, and ongoing transformation that may take 2-3 years to fully realize. The company is in a transitional phase with earnings volatility, making it less ideal for short-term trading. A minimum holding period of 2-3 years is suggested to allow the spin-off benefits to materialize and for the automation strategy to gain traction. Short-term traders might exploit the range between $195.87 and $260.28, but the risk/reward is less favorable given the lack of clear momentum.
